Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

14 Feb 2022 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated February 14, 2022, titled ‘Zydus gets 180 day shared exclusivity for Roflumilast Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..